This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: University of Florida Research Foundation Inc., Emory University, University of Rochester. Active years: 2011-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gainsville, FL (US) (2016)
- Gainesville, FL (US) (2011 - 2022)
Company Filing History:
2 out of 3,050 
1 out of 1,024 
1 out of 994 
Years Active: 2011-2022
Title: The Innovations of Maurice Scott Swanson
Introduction
Maurice Scott Swanson is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of medical research, particularly in the treatment of myotonic dystrophy. With a total of 3 patents, his work focuses on innovative methods to address cognitive impairments associated with this condition.
Latest Patents
Swanson's latest patents include groundbreaking methods for treating conditions associated with myotonic dystrophy. One patent discloses methods for treating central nervous system dysfunction and cognitive impairment by administering a therapeutically effective amount of a GABAA receptor antagonist or inverse agonist. Another patent outlines methods for treating diseases caused by mis-splicing of GABRG2, also utilizing GABAA receptor antagonists. Additionally, he has developed methods aimed at improving cognitive function in subjects with myotonic dystrophy through similar therapeutic approaches. Examples of the GABAA receptor antagonists include flumazenil, clarithromycin, and picrotoxin, among others. His work also encompasses compositions and methods related to protein displacement therapy for myotonic dystrophy, focusing on the interaction of polyCUG and polyCCUG repeat RNA with muscleblind proteins.
Career Highlights
Swanson has worked with esteemed institutions such as the University of Florida Research Foundation Inc and Emory University. His research has been pivotal in advancing the understanding and treatment of myotonic dystrophy.
Collaborations
Some of his notable coworkers include Charles A. Thornton and Gary J. Bassell, who have contributed to his research endeavors.
Conclusion
Maurice Scott Swanson's innovative work in the treatment of myotonic dystrophy highlights his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of this condition and offer hope for improved therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile